Mar 06, 2018 13:01 pm UTC| Business
URIROX-1TM is the Largest Controlled Trial of a Novel Therapeutic for this Underserved Patient Population - Topline Data Expected in Second Half of 2019 -ALLN-177 has Potential to be the First FDA-Approved Treatment for...
Dawn Rana Joins Furnished Quarters as Director of Corporate Sales
Mar 06, 2018 13:01 pm UTC| Business
New York, NY, March 06, 2018 -- Furnished Quarters, the largest independently owned and operated provider of temporary furnished apartments, announced today that Dawn Rana has joined the company as Director of Corporate...
Mar 06, 2018 13:01 pm UTC| Business
TORONTO, March 06, 2018 -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of...
World Micro Announces Franchise Distribution Agreement with Jianghai
Mar 06, 2018 13:01 pm UTC| Business
ATLANTA, GA, March 06, 2018 -- Atlanta-based electronics distributor, World Micro Inc., announced today that it has signed a new franchise distribution agreement with Jianghai America Inc. The newly formed franchise...
GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer
Mar 06, 2018 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 06, 2018 -- Global Blood Therapeutics, Inc. (GBT or the “Company”) (Nasdaq:GBT) today announced the appointment of David L. Johnson as chief commercial officer, effective March 12,...
PhaseBio to Present at March Investor Conferences
Mar 06, 2018 13:01 pm UTC| Business
MALVERN, Pa., March 06, 2018 -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that Chief Executive Officer Jonathan...
CareDx to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on March 22, 2018
Mar 06, 2018 13:01 pm UTC| Business
BRISBANE, Calif., March 06, 2018 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...